Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Quarta

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Revista Espanola De Cardiologia (English Ed.)|May 25, 2012
Diagnostic criteria for arrhythmogenic right ventricular cardiomyopathyGiovanni Quarta, Perry M Elliott
British Journal of Sports Medicine|December 1, 2009
Beyond sudden death in the athlete: how to identify family members at riskGiovanni Quarta, Pier Lambiase, Perry Elliott
Giornale Italiano Di Cardiologia (2006)|April 4, 2015
[Risk of sudden death according to the latest European guidelines on hypertrophic cardiomyopathy]Attilio Iacovoni, Giovanni Quarta, Michele Senni
Current Treatment Options in Cardiovascular Medicine|January 29, 2008
Risk stratification and prevention of sudden death in hypertrophic cardiomyopathyCamillo Autore, Giovanni Quarta, Paolo Spirito
Frontiers in Cardiovascular Medicine|October 2, 2023
Editorial: Comprehensive risk prediction in cardiomyopathies: new genetic and imaging markers of risk, volume IINuno Cardim, Luis Rocha Lopes, Giovanni Quarta
Clinical Therapeutics|August 6, 2010
Retrospective case series of three patients with plasma cell leukemia treated with bortezomib-based regimensGiuseppe Mele, Salvatore Pinna, Angela Melpignano, et al.
Clinical and Experimental Medicine|January 21, 2015
Paralytic ileus following "subcutaneous bortezomib" therapy: focus on the clinical emergency-report of two casesGiuseppe Mele, Maria Rosaria Coppi, Angela Melpignano, et al.
Frontiers in Cardiovascular Medicine|March 29, 2022
Editorial: Comprehensive Risk Prediction in Cardiomyopathies: New Genetic and Imaging Markers of RiskLuis Rocha Lopes, Giovanni Quarta, Nuno Cardim, et al.
Giornale Italiano Di Cardiologia (2006)|December 7, 2018
[Clinical applications of cardiac magnetic resonance imaging: heart failure and cardiomyopathies]Patrizia Pedrotti, Stefano Pedretti, Massimo Imazio, et al.
Leukemia Research|August 8, 2006
Inefficacy of bortezomib therapy for CNS involvement of refractory multiple myelomaGiuseppe Mele, Salvatore Pinna, Emilia Alloro, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Revista Espanola De Cardiologia (English Ed.)|May 25, 2012
Diagnostic criteria for arrhythmogenic right ventricular cardiomyopathyGiovanni Quarta, Perry M Elliott
British Journal of Sports Medicine|December 1, 2009
Beyond sudden death in the athlete: how to identify family members at riskGiovanni Quarta, Pier Lambiase, Perry Elliott
Giornale Italiano Di Cardiologia (2006)|April 4, 2015
[Risk of sudden death according to the latest European guidelines on hypertrophic cardiomyopathy]Attilio Iacovoni, Giovanni Quarta, Michele Senni
Current Treatment Options in Cardiovascular Medicine|January 29, 2008
Risk stratification and prevention of sudden death in hypertrophic cardiomyopathyCamillo Autore, Giovanni Quarta, Paolo Spirito
Frontiers in Cardiovascular Medicine|October 2, 2023
Editorial: Comprehensive risk prediction in cardiomyopathies: new genetic and imaging markers of risk, volume IINuno Cardim, Luis Rocha Lopes, Giovanni Quarta
Clinical Therapeutics|August 6, 2010
Retrospective case series of three patients with plasma cell leukemia treated with bortezomib-based regimensGiuseppe Mele, Salvatore Pinna, Angela Melpignano, et al.
Clinical and Experimental Medicine|January 21, 2015
Paralytic ileus following "subcutaneous bortezomib" therapy: focus on the clinical emergency-report of two casesGiuseppe Mele, Maria Rosaria Coppi, Angela Melpignano, et al.
Frontiers in Cardiovascular Medicine|March 29, 2022
Editorial: Comprehensive Risk Prediction in Cardiomyopathies: New Genetic and Imaging Markers of RiskLuis Rocha Lopes, Giovanni Quarta, Nuno Cardim, et al.
Giornale Italiano Di Cardiologia (2006)|December 7, 2018
[Clinical applications of cardiac magnetic resonance imaging: heart failure and cardiomyopathies]Patrizia Pedrotti, Stefano Pedretti, Massimo Imazio, et al.
Leukemia Research|August 8, 2006
Inefficacy of bortezomib therapy for CNS involvement of refractory multiple myelomaGiuseppe Mele, Salvatore Pinna, Emilia Alloro, et al.
Pageof 9